Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Strata Oncology provides precision oncology solutions integrating molecular profiling with decision support to match cancer patients to optimal therapies and clinical trials. Its flagship product, StrataNGS—a tissue-based NGS panel—enables comprehensive genomic profiling of solid tumors. The company also develops advanced algorithmic biomarkers to predict benefit from antibody-drug conjugates and immunotherapies. Ongoing initiatives include a large-scale "Sentinel" study validating a personalized liquid biopsy assay for minimal residual disease detection and recurrence monitoring in early-stage cancer patients. The company runs the "Strata PATH" pan-tumor therapeutic trial evaluating biomarker-guided use of FDA-approved drugs across multiple classes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Strata Oncology.